EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SURGE THERAPEUTICS was filed as Word mark on 11/12/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/26/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018599494 |
| Application date | November 12, 2021 |
| Publication date | December 17, 2021 |
| Entry date | March 26, 2022 |
| Expiration date | November 12, 2031 |
Trademark owner
20 Chapel Street, B712
02446 Brookline
US
02446 Brookline
US
Trademark representatives
Harcourt Centre, Block 4 Harcourt Road
D02 HW77 Dublin
IE
goods and services
5
Hydrogel for medical purposes; biomaterial for medical purposes; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; intraoperative biomaterial for delivery of immunotherapy
42
Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing scientific research information in the fields of oncology and immunotherapy via a website
ID: 11018599494